Second Ebola vaccine to be used in DR Congo next month

 

 

Doctors will use a second Ebola vaccine from November in three eastern provinces in the Democratic Republic of Congo to fight the deadly virus, medical officials said Sunday.

“It’s time to use the new Ad26-ZEBOV-GP vaccine, manufactured by Johnson & Johnson’s Belgian subsidiary,” said Dr. Jean-Jacques Muyembe, who leads the national anti-Ebola operation in the DRC.

It will arrive in the eastern city of Goma, in North Kivu province, on October 18 and be used from the beginning of next month, he added.

DRC’s latest Ebola epidemic, which began in August 2018, has killed 2144 people, making it the second deadliest outbreak of the virus, after the West Africa pandemic of 2014-2016.

Muyembe said the communes of Majingo and Kahembe had been selected to receive the vaccine as they were considered the epicentres of the epidemic.

“We will extend this vaccination to our small traders who often go to Rwanda to protect our neighbours,” he added.

“If it works well, we will expand vaccination in South Kivu and Ituri.”

DR Congo’s eastern provinces of Ituri, North Kivu and South Kivu sit on the borders with Uganda, Rwanda and Burundi.

The Belgian laboratory will send a batch of 200 000 doses to neighbouring Rwanda and 500 000 doses in the DRC, Muyembe said.

More than 237 000 people living in active Ebola transmission zones have received a vaccination produced by the pharma company Merck Sharpe and Dohme since August 8, 2018.

The J&J vaccine had been rejected by DRC’s former health minister Oly Ilunga, who cited the risks of introducing a new product in communities where mistrust of Ebola responders is already high.

But Ilunga’s resignation in July appears to have paved the way for approval of the second vaccine. He currently faces charges that he embezzled funds intended for the fight against Ebola.

In his letter of resignation Ilunga said “actors who have demonstrated a lack of ethics” want to introduce a second vaccine, but did not elaborate.

Muyembe, who took over the Ebola fight in the DRC in July, said “The Johnson & Johnson vaccine has the most science-based data.”

© Agence France-Presse

Keep the powerful accountable

Subscribe for R30/mth for the first three months. Cancel anytime.

Subscribers get access to all our best journalism, subscriber-only newsletters, events and a weekly cryptic crossword.

Agency
External source

Related stories

WELCOME TO YOUR M&G

Already a subscriber? Sign in here

Advertising

Latest stories

China’s off-roader seeks a niche in SA with its BAIC...

Beijing is hoping that its BAIC B40 Plus will replicate legendary off-roading on a budget

Unvaccinated South Africans to pay more for insurance premiums

Insurance companies have adjusted their premiums and people who are not vaccinated will pay more for cover

Disposable masks are the latest pollution problem

Waste management institute says we should wear reusable masks and learn how to responsibly dispose of old masks

How to track your R350 Covid-19 relief grant

All beneficiaries who applied for the R350 relief grant before July 2021, must reapply. Here is how to track your application status
Advertising

press releases

Loading latest Press Releases…
×